SSW
BIIB icon

Smith Shellnut Wilson’s Biogen BIIB Stock Holding History

Smith Shellnut Wilson’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-941
Closed -$300K – 120
2017
Q4 		$300K Hold
941
– – 0.25% 87
2017
Q3 		$295K Sell
941
-209
-18% -$61.9K 0.26% 83
2017
Q2 		$278K Sell
1,150
-55
-5% -$14.5K 0.29% 84
2017
Q1 		$329K Hold
1,205
– – 0.3% 75
2016
Q4 		$342K Buy
+1,205
New +$357K 0.33% 66

Other funds holding BIIB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Smith Shellnut Wilson's BIIB Position: Q1 2018 in Review

Smith Shellnut Wilson sold out of Biogen (BIIB) in Q1 2018, closing a stake of 941 shares — an estimated $300K sold.

Smith Shellnut Wilson first reported a position in BIIB in Q4 2016 and held it in 5 quarters. The position peaked at $342K in Q4 2016. 1,103 funds tracked by Wall St. Rank hold BIIB as of Q1 2018.

  • Smith Shellnut Wilson reported no remaining Biogen position as of Q1 2018 after selling out during the quarter.
  • Smith Shellnut Wilson sold 941 Biogen shares in Q1 2018, an estimated $300K.
  • Smith Shellnut Wilson first reported a position in Biogen in Q4 2016 and held it in 5 quarters.
  • Smith Shellnut Wilson's Biogen position peaked at $342K in Q4 2016.
  • 1,103 funds tracked by Wall St. Rank held Biogen as of Q1 2018.

Based on Smith Shellnut Wilson's 13F filing for Q1 2018, filed 24 Apr 2018.